Hedgehog-interacting protein is highly expressed in endothelial cells but down-regulated during angiogenesis and in several human tumors

BMC Cancer

Volumn 4, Issue , 2004, Pages

  Olsen, Catherine L ^a   Hsu, Pin Pin ^a,c   Glienke, Jens ^b   Rubanyi, Gabor M ^a   Brooks, Alan R ^a  

^a BAYER AG   (Germany)

^b BAYER PHARMA AG   (Germany)

^c EXELIXIS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SONIC HEDGEHOG PROTEIN; CARRIER PROTEIN; CELL SURFACE RECEPTOR; HHIP PROTEIN, HUMAN; HHIP PROTEIN, MOUSE; MEMBRANE PROTEIN; PATCHED RECEPTORS; PROTEIN; SHH PROTEIN, HUMAN; SIGNAL PEPTIDE; TRANSACTIVATOR PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL TYPE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG CANCER; MALE; MOUSE; NONHUMAN; PROSTATE CANCER; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; RNA ISOLATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR CLASSIFICATION; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING; ANIMAL; CELL DIVISION; DRUG ANTAGONISM; GENETICS; LEYDIG CELL; METABOLISM; MOLECULAR GENETICS; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); NUCLEOTIDE SEQUENCE; NUDE MOUSE; TUMOR CELL CULTURE; XENOGRAFT;

ANIMALS; BASE SEQUENCE; CARRIER PROTEINS; CELL DIVISION; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; HEDGEHOG PROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEYDIG CELLS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEINS; RECEPTORS, CELL SURFACE; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 13144298531     PISSN: 14712407     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2407-4-43     Document Type: Article

References (33)

1. Kalderon D: Transducing the hedgehog signal. Cell 2000, 103:371-374.
2. Nybakken K, Perrimon N: Hedgehog signal transduction: recent findings. Curr Opin Genet Dev 2002, 12:503-511.
3. Marigo V, Tabin CJ: Regulation of Patched by Sonic hedgehog in the developing neural tube. P Natl Acad Sci USA 1996, 93:9346-9351.
4. Chuang PT, McMahon AP: Vertebrate hedgehog signalling modulated by induction of a Hedgehog-binding protein. Nature 1999, 397:617-621.
5. Zeng X, Goetz JA, Suber LM, Scott WJ, Schreiner CM, Robbins DM: A freely diffusible form of Sonic hedgehog mediates longrange signalling. Nature 2001, 411:716-720.
6. Dyer MA, Farrington SM, Mohn D, Munday JR, Baron MH: Indian hedgehog activates hematopoiesis and vasculogenesis and can respecify prospective neurectodermal cell fate in the mouse embryo. Development 2001, 128:1717-1730.
7. Pola R, Ling LE, Silver M, Corbley MJ, Kearney M, Pepinsky RB, Shapiro R, Taylor FR, Baker DP, Asahara T, Isner JM: The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nature Med 2001, 7:706-711.
8. Pola R, Ling LE, Aprahamian TR, Barban E, Bosch-Marce M, Curry C, Corbley M, Kearney M, Isner JM, Losordo DW: Postnatal recapitulation of embryonic hedgehog pathway in response to skeletal muscle ischemia. Circulation 2003, 108:479-485.
9. Byrd N, Becker S, Maye P, Narasimhaiah R, St-Jacques B, Zhang X, McMahon J, McMahon A, Grabel L: Hedgehog is required for murine yolk sac angiogenesis. Development 2002, 129:361-372.
10. Ruiz i Altaba A, Sanchez P, Dahmane N: Gli and Hedgehog in cancer: tumours, embryos and stem cells. Nature Reviews 2002, 2:361-372.
11. Hahn H, Wicking C, Zaphiropoulos PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Unden AB, Gillies S, Negus K, Smyth I, Pressman C, Leffell DJ, Gerrard B, Goldstein AM, Dean M, Toftgard R, Chenevix-Trench G, Wainwright B, Bale AE: Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996, 85:841-851.
12. Kinzler KW, Bigner SH, Bigner DD, Trent JM, Law ML, O'Brien SJ, Wong AJ, Vogelstein B: Identification of an amplified, highly expressed gene in a human glioma. Science 1987, 236:70-73.
13. Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K, Parker AR, Shimada Y, Eshleman JR, Watkins DN, Beachy PA: Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003, 425: 46-851.
14. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernandez-del Castillo C, Yajnik V, Antoniu B, McMahon M, Warshaw AL, Hebrok M: Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003, 425:851-856.
15. Watkins DN, Berman DM, Burkholder SG, Wang B, Beachy PA, Baylin SB: Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 2003, 422:313-317.
16. Folkman J, Shing Y: Angiogenesis. J Biol Chem 1992, 267:10931-10934.
17. Folkman J: Angiogenesis and apoptosis. Semin Cancer Biol 2003, 13:159-167.
18. Yamaoka M, Yamamoto T, Ikeyama S, Sudo K, Fujita T: Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Cancer Res 1993, 53:5233-5236.
19. Wedge SR, Ogilvie DJ, Dukes M, Kendrew J, Chester R, Jackson JA, Boffey SJ, Valentine PJ, Curwen JO, Musgrove HL, Graham GA, Hughes GD, Thomas AP, Stokes ESE, Curry B, Richmond GHP, Wadsworth PF, Bigley AL, Hennequin LF: ZD6474 Inhibits Vascular Endothelial Growth Factor Signaling, Angiogenesis, and Tumor Growth following Oral Administration. Cancer Res 2002, 62:4645-4655.
20. Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86: 53-364.
21. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wiegand SJ: Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999, 284:1994-1998.
22. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J: Vascular-specific growth factors and blood vessel formation. Nature 2000, 407:242-248.
23. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MAS, Hajjar KA, Manova K, Benezra R, Rafii S: Impaired recruitment of bone marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature Med 2001, 7:1194-1201.
24. Bonifas JM, Pennypacker S, Chuang PT, McMahon AP, Williams M, Rosenthal A, De Sauvage FJ, Epstein EH: Activation of expression of hedgehog target genes in basal cell carcinomas. J Invest Dermatol 2001, 116:739-742.
25. Dahmane N, Lee J, Robins P, Heller P, Ruiz i Altaba A: Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature 1997, 389: 76-881.
26. Dahmane N, Sanchez P, Gitton Y, Palma V, Sun T, Beyna M, Weiner H, Ruiz i Altaba A: The sonic hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. Development 2001, 128: 201-5212.
27. Tojo M, Kiyosawa H, Iwatsuki K, Kaneko F: Expression of a sonic hedgehog signal transducer, hedgehog-interacting protein, by human basal cell carcinoma. Brit J Dermatol 2002, 146:69-73.
28. Vogt A, Chuang P-T, Hebert J, Hwang J, Lu Y, Kopelovich L, Athar M, Bickers DR, Epstein EH Jr: Immunoprevention of Basal Cell Carcinomas with Recombinant Hedgehog-interacting Protein. J Exp Med 2004, 199:753-761.
29. Hu Z, Bonifas JM, Aragon G, Kopelovich L, Liang Y, Ohta S, Israel M, Bickers DR, Aszterbaum M, Epstein EH: Evidence for lack of enhanced hedgehog target gene expression in common extracutaneous tumors. Cancer Res 2003, 63:923-928.
30. Fernandez A, Udagawa T, Schwesinger C, Beecken WD, Achilles-Gerte E, McDonnell TJ, D'Amato RJ: Angiogenic potential of prostate carcinoma cells overexpressing bcl-2. J Natl Cancer I 2001, 93:208-212.
31. Gavish Z, Pinthus JH, Barak V, Ramon J, Nagler A, Eshhar Z, Pines M: Growth inhibition of prostate cancer xenografts by halofuginone. The Prostate 2002, 51:73-83.
32. Carmeliet P, Jain RK: Angiogenesis in cancer and other diseases. Nature 2000, 407:246-257.
33. Scappaticci FA: The therapeutic potential of novel antiangiogenic therapies. Expert Opin Inv Drugs 2003, 12: 23-932.